SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-03-000452
Filing Date
2003-02-14
Accepted
2003-02-14 14:02:00
Documents
1
Group Members
BIOTECH FOCUS N.V.

Document Format Files

Seq Description Document Type Size
1 MEDIMMUNE, INC. SCHEDULE 13G w83576fsc13gza.htm SC 13G/A 19275
  Complete submission text file 0000950133-03-000452.txt   21353
Mailing Address 35 W WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 35 W WATKINS MILL RD GAITHERSBURG MD 20878 3014170770
MEDIMMUNE INC /DE (Subject) CIK: 0000873591 (see all company filings)

IRS No.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42057 | Film No.: 03565968
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 0000